↓ Skip to main content

The HysNiche trial: hysteroscopic resection of uterine caesarean scar defect (niche) in patients with abnormal bleeding, a randomised controlled trial

Overview of attention for article published in BMC Women's Health, November 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
1 X user
wikipedia
1 Wikipedia page

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The HysNiche trial: hysteroscopic resection of uterine caesarean scar defect (niche) in patients with abnormal bleeding, a randomised controlled trial
Published in
BMC Women's Health, November 2015
DOI 10.1186/s12905-015-0260-8
Pubmed ID
Authors

A. J. M. W. Vervoort, L. F. Van der Voet, M. Witmer, A. L. Thurkow, C. M. Radder, P. J. M. van Kesteren, H. W. P. Quartero, W. K. H. Kuchenbecker, M. Y. Bongers, P. M. A. J. Geomini, L. H. M. de Vleeschouwer, M. H. A. van Hooff, H. A. A. M. van Vliet, S. Veersema, W. B. Renes, H. S. van Meurs, J. Bosmans, K. Oude Rengerink, H. A. M. Brölmann, B. W. J. Mol, J. A. F. Huirne

Abstract

A caesarean section (CS) can cause a defect or disruption of the myometrium at the site of the uterine scar, called a niche. In recent years, an association between a niche and postmenstrual spotting after a CS has been demonstrated. Hysteroscopic resection of these niches is thought to reduce spotting and menstrual pain. However, there are no randomised trials assessing the effectiveness of a hysteroscopic niche resection. We planned a multicentre randomised trial comparing hysteroscopic niche resection to no intervention. We study women with postmenstrual spotting after a CS and a niche with a residual myometrium of at least 3 mm during sonohysterography. After informed consent is obtained, eligible women will be randomly allocated to hysteroscopic resection of the niche or expectant management for 6 months. The primary outcome is the number of days with postmenstrual spotting during one menstrual cycle 6 months after randomisation. Secondary outcomes are menstrual characteristics, menstruation related pain and experienced discomfort due to spotting or menstrual pain, quality of life, patient satisfaction, sexual function, urological symptoms, medical consultations, medication use, complications, lost productivity and medical costs. Measurements will be performed at baseline and at 3 and 6 months after randomisation. A cost-effectiveness analysis will be performed from a societal perspective at 6 months after randomisation. This trial will provide insight in the (cost)effectiveness of hysteroscopic resection of a niche versus expectant management in women who have postmenstrual spotting and a niche with sufficient residual myometrium to perform a hysteroscopic niche resection. Dutch Trial Register NTR3269 . Registered 1 February 2012. ZonMw Grant number 80-82305-97-12030.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 112 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 13%
Researcher 9 8%
Student > Ph. D. Student 8 7%
Student > Postgraduate 7 6%
Student > Master 7 6%
Other 18 16%
Unknown 48 43%
Readers by discipline Count As %
Medicine and Dentistry 40 36%
Nursing and Health Professions 5 4%
Biochemistry, Genetics and Molecular Biology 4 4%
Environmental Science 2 2%
Psychology 2 2%
Other 7 6%
Unknown 52 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 October 2023.
All research outputs
#7,094,970
of 24,666,614 outputs
Outputs from BMC Women's Health
#893
of 2,170 outputs
Outputs of similar age
#83,603
of 288,220 outputs
Outputs of similar age from BMC Women's Health
#16
of 33 outputs
Altmetric has tracked 24,666,614 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,170 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,220 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.